AGÕæÈ˹ٷ½

STOCK TITAN

Eltek Ltd. Reports Strong Second-Quarter 2025 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Eltek Ltd. (NASDAQ: ELTK), a PCB solutions manufacturer, reported strong Q2 2025 results with revenues of $12.5 million, up 20% year-over-year. The company achieved significant improvements in profitability, with gross margin expanding to 24.1% from 15.6% and operating income surging to $1.5 million, a 259% increase.

Despite operational success, currency headwinds resulted in a $1.0 million financial expense due to shekel appreciation. Net income was $0.4 million ($0.05 per share), compared to $0.8 million ($0.11 per share) in Q2 2024. The company's expansion plans continue with successful equipment installations, though their new coating lines delivery has been delayed to late 2025.

Eltek Ltd. (NASDAQ: ELTK), produttore di soluzioni PCB, ha riportato solidi risultati per il secondo trimestre 2025 con ricavi di $12.5 million, in crescita del 20% su base annua. L'azienda ha ottenuto significativi miglioramenti della redditività: il margine lordo è salito a 24.1% rispetto al 15.6% e il risultato operativo è aumentato a $1.5 million, un incremento del 259%.

Nonostante il successo operativo, venti contrari valutari hanno comportato una $1.0 million financial expense a causa dell'apprezzamento dello shekel. L'utile netto è stato di $0.4 million (pari a $0.05 per azione), rispetto a $0.8 million ($0.11 per azione) nel Q2 2024. I piani di espansione proseguono con l'installazione delle attrezzature completata con successo, sebbene la consegna delle nuove linee di rivestimento sia stata posticipata alla fine del 2025.

Eltek Ltd. (NASDAQ: ELTK), fabricante de soluciones PCB, presentó sólidos resultados en el segundo trimestre de 2025 con ingresos de $12.5 million, un aumento del 20% interanual. La compañía logró mejoras significativas en la rentabilidad: el margen bruto se amplió hasta el 24.1% desde el 15.6% y el resultado operativo se disparó hasta $1.5 million, un crecimiento del 259%.

A pesar del éxito operativo, vientos en contra cambiarios provocaron una $1.0 million financial expense debido a la apreciación del shekel. El beneficio neto fue de $0.4 million ($0.05 por acción), frente a $0.8 million ($0.11 por acción) en el Q2 de 2024. Los planes de expansión continúan con la instalación exitosa de equipos, aunque la entrega de las nuevas líneas de recubrimiento se ha retrasado hasta finales de 2025.

Eltek Ltd. (NASDAQ: ELTK), PCB 솔루ì…� 제조업체ì� ì� 회사ëŠ� 2025ë…� 2분기ì—� 매출 $12.5 millionì� 기ë¡í•˜ë©° ì „ë…„ ë™ê¸° 대ë¹� 20% ì¦ê°€í•� 견조í•� 실ì ì� 발표했습니다. 수ìµì„±ë„ í¬ê²Œ 개선ë˜ì–´ 매출ì´ì´ìµë¥ ì� 15.6%ì—서 24.1%ë¡� 확대ë˜ì—ˆê³�, ì˜ì—…ì´ìµì€ $1.5 million으로 259% 급ì¦í–ˆìŠµë‹ˆë‹¤.

다만 통화 ì—­í’으로 셰켈 강세ì—� 따른 $1.0 million financial expenseê°€ ë°œìƒí–ˆìŠµë‹ˆë‹¤. 순ì´ìµì€ $0.4 million(주당 $0.05)으로, 2024ë…� 2분기ì� $0.8 million(주당 $0.11)ì—� 비해 ê°ì†Œí–ˆìŠµë‹ˆë‹¤. 설비 설치ëŠ� 성공ì ìœ¼ë¡� ì§„í–‰ë˜ì–´ 확장 계íšì€ 계ì†ë˜ì§€ë§�, 새로ìš� 코팅 ë¼ì¸ì� ì¸ë„ëŠ� 2025ë…� ë§ë¡œ 지연ë˜ì—ˆìŠµë‹ˆë‹¤.

Eltek Ltd. (NASDAQ: ELTK), fabricant de solutions PCB, a annoncé de solides résultats pour le T2 2025 avec un chiffre d'affaires de $12.5 million, en hausse de 20% en glissement annuel. La rentabilité s'est nettement améliorée : la marge brute est passée de 15.6% à 24.1% et le résultat d'exploitation a bondi à $1.5 million, soit une augmentation de 259%.

Malgré ce succès opérationnel, des vents contraires liés aux changes ont entraîné une $1.0 million financial expense en raison de l'appréciation du shekel. Le résultat net s'est établi à $0.4 million (soit $0.05 par action), contre $0.8 million ($0.11 par action) au T2 2024. Les projets d'expansion se poursuivent avec des installations d'équipements réussies, bien que la livraison des nouvelles lignes de revêtement ait été reportée à la fin de 2025.

Eltek Ltd. (NASDAQ: ELTK), ein Hersteller von PCB-Lösungen, meldete für das zweite Quartal 2025 starke Ergebnisse mit Umsätzen von $12.5 million, ein Plus von 20% gegenüber dem Vorjahr. Das Unternehmen erzielte deutliche Verbesserungen bei der Profitabilität: die Bruttomarge stieg von 15.6% auf 24.1% und das operative Ergebnis kletterte auf $1.5 million, ein Anstieg um 259%.

Trotz des operativen Erfolgs führten Währungsgegenwinde aufgrund der Aufwertung des Schekels zu einem $1.0 million financial expense. Der Nettogewinn lag bei $0.4 million ($0.05 je Aktie) gegenüber $0.8 million ($0.11 je Aktie) im Q2 2024. Die Expansionspläne werden mit erfolgreich installierten Anlagen fortgeführt, allerdings wurde die Lieferung der neuen Beschichtungs­linien auf Ende 2025 verschoben.

Positive
  • Revenue grew 20% year-over-year to $12.5 million
  • Gross margin expanded significantly to 24.1% from 15.6%
  • Operating income increased 259% to $1.5 million
  • EBITDA improved to $2.0 million (15.6% of revenues) from $0.8 million
  • Workforce expanded by 10% since January to meet growing demand
Negative
  • Currency fluctuations led to $1.0 million financial expense due to shekel appreciation
  • Net income decreased to $0.4 million from $0.8 million year-over-year
  • Delayed delivery of new coating lines to end of 2025
  • Earnings per share declined to $0.05 from $0.11 in Q2 2024

Insights

Eltek reports strong Q2 with 20% revenue growth and tripled operating profit, despite currency headwinds impacting bottom line.

Eltek's Q2 2025 results demonstrate solid operational momentum with $12.5 million in revenue, a 20% year-over-year increase driven primarily by strength in defense and medical segments. The gross margin expanded significantly to 24.1% from 15.6% in Q2 2024, reflecting improved operational efficiency and favorable product mix.

Operating income saw remarkable growth, surging to $1.5 million - more than triple the $0.4 million recorded in the same period last year. This 259% increase underscores the company's improved operational leverage.

However, currency fluctuations created substantial headwinds. The 9% appreciation of the Israeli shekel against the USD resulted in a $1.0 million non-cash financial expense, compared to financial income of $0.5 million in Q2 2024. This currency impact was the primary factor in the reduced net income, which fell to $0.4 million ($0.05 per share) from $0.8 million ($0.11 per share) a year ago.

The EBITDA metric shows underlying business strength, reaching $2.0 million (15.6% of revenues) versus $0.8 million (7.6%) in Q2 2024 - a substantial improvement in operational profitability.

Eltek continues to execute on its capacity expansion plan, though with some delays in equipment delivery. The company has increased staffing by approximately 10% since January to meet growing demand. Management has also implemented pricing model adjustments to mitigate future currency impacts, which should help protect margins going forward.

For the first half of 2025, Eltek reported revenue of $25.3 million, up 14% year-over-year, with net profit of $1.4 million compared to $2.5 million in H1 2024 - a decrease primarily attributable to currency effects rather than operational challenges.

20% Quarter-over-quarter revenue growth; gross margin expands to 24%

PETACH TIKVA, Israel, Aug. 14, 2025 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), today announced its financial results for the quarter ended June 30, 2025.

Eltek Logo

Ìý

Second Quarter 2025 Highlights


Q2 2025

Q2 2024

%

Ìý Ìý ÌýRevenues (*)

$12.5 million

$10.5 million

+20Ìý%

Ìý Ìý ÌýGross margin

24.1Ìý%

15.6Ìý%

+8.5Ìý%

Ìý Ìý ÌýOperating income

$1.5 million

$0.4 million

+259Ìý%

Ìý Ìý ÌýFinancial income (expense)

$(1.0) million

$0.5 million

n/m


(*) Revenues for the six months ended June 30, 2025 totaled $25.3 million, up 14%
from $22.2 million in the 2024 period.

Eli Yaffe, Chief Executive Officer, stated:

"Strong momentum across our defense and medical segments drove significant year-over-year growth, highlighted by double-digit revenue increases. Continued operational improvements and a favorable product mix (compared to Q2 2024) contributed to a substantial increase in gross margin and operating profit, which reached $1.5 million - more than triple the amount recorded in the same period last year.

We remain committed to expanding our production capacity. All the equipment that was delivered to date has been successfully installed and is performing in accordance with specifications. Construction to accommodate the core of our investment plan - the new 60-meter coating lines is progressing smoothly, on schedule, and without any material impact on ongoing production operations. Following a recent scheduling update from our coating lines supplier, we have been informed of an additional delay in the delivery of the first line. We now expect the first line to arrive at our facility toward the end of 2025.

With staffing up approximately 10% since January, we continue our efforts to meet growing demand while maintaining best-in-class lead times.

The sharp appreciation of the Israeli shekel during the quarter resulted in a non-cash financial expense of $1.0 million. Given that the majority of our revenues are denominated in U.S. dollars, we have proactively updated our pricing model to better align with our NIS-based expenses. The impact of the currency fluctuation will be reflected in future customer orders, helping to protect our margins moving forward."

Second Quarter 2025 GAAP Financial Results

RevenuesÌýfor the second quarter of 2025 were $12.5Ìýmillion compared to $10.5 million in the second quarter of 2024.

Gross profitÌýfor the second quarter of 2025 was $3.0Ìýmillion (24% of revenues) compared to $1.6 millionÌý(16% of revenues) in the second quarter of 2024.

Operating profit for the second quarter of 2025 was $1.5 million compared to operating profit of $0.4 million in the second quarter of 2024.

Financial expenses for the second quarter of 2025 were $1.0 million compared to financial income of $0.5 million in the second quarter of 2024. Financial expenses primarily resulted from the 9% erosion of the U.S. dollar against the NIS.

Net income for the second quarter of 2025 was $0.4 million or $0.05 per fully diluted share compared to net income of $0.8 million or $0.11 per fully diluted share in the second quarter of 2024.

Second Quarter 2025 Non-GAAP Financial Results

EBITDA for the second quarter of 2025 was $2.0 million (15.6% of revenues) compared to EBITDA of $0.8 million (7.6% of revenues) in the second quarter of 2024.

Six Months Ended June 30, 2025 GAAP Financial Results

RevenuesÌýfor the first six months of 2025 were $25.3 million compared to $22.2 million in the first six months of 2024.

Gross profitÌýfor the first six months of 2025 was $5.2 million (21% of revenues) compared to $4.9 million (22% of revenues) in the first six months of 2024.

Operating profit for the first six months of 2025 was $2.2 million compared to operating profit of $2.1 million in the first six months of 2024.

Financial expensesÌýfor the first six months of 2025 were $0.5 million compared to financial income of $0.8 million in the first six months of 2024. Financial expenses primarily resulted from the erosion of the U.S. dollar against the NIS.

Net profit for the first six months of 2025 was $1.4 million or $0.20 per fully diluted share compared to net profit of $2.5 million or $0.38 per fully diluted share in the first six months of 2024.

Six Months Ended June 30, 2025 Non-GAAP Financial Results

EBITDA for the first six months of 2025 was a $3.1 million (12% of revenues) compared to EBITDA of $2.9 million (13% of revenues) in the first six months of 2024.

About our Non-GAAP Financial Information

The Company reports financial results in accordance with U.S. GAAP and herein provides EBITDA, a non-GAAP measure. This non-GAAP measure is not in accordance with, nor is it a substitute for, GAAP measures. This non-GAAP measure is intended to supplement the Company's presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measure presented to evaluate and manage the Company's operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the Company's results on a GAAP and non-GAAP basis is provided in a table below.

Conference Call

Today, Thursday, August 14, 2024, at 9:00am Eastern Time (16:00pm Israel Time, 6:00am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks by Eli Yaffe, Chief Executive Officer and Ron Freund, Chief Financial Officer.

To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:

United States:Ìý Ìý Ìý Ìý Ìý Ìý Ìý1-866-860-9642
Israel:ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý 03-918-0691
International:ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý +972-3-918-0691

To Access a Replay of the Call

A replay of the call will be available for 30 days on the Investor Info section on Eltek's corporate website at Ìýapproximately 24 hours after the conference call is completed.

About Eltek

Eltek � "Innovation Across the Board", is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs) and is an Israeli leading company in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high-quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.

Eltek was founded in 1970. The Company's headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and distributors in Europe, India, South Africa and South America.

For more information, visit Eltek's web site at

Forward Looking Statement

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.

Investor Contact

Ron Freund
Chief Financial Officer
[email protected]
+972-3-939-5023

Ìý

Eltek Ltd.

Consolidated Statements of Income

U.S dollars in thousands (except per share data)




































Three months ended


Six months ended





June 30,


June 30,





2025


2024


2025


2024























Revenues


12,529


10,466


25,285


22,249



Costs of revenues


(9,510)


(8,830)


(20,054)


(17,361)














Gross profit


3,019


1,636


5,231


4,888














Research and development expenses, net


-


(47)


(50)


(62)



Selling, general and administrative expenses


(1,563)


(1,184)


(3,000)


(2,700)














Operating profit


1,456


405


2,181


2,126














Financial income (expense), net


(1,012)


489


(508)


839














Income before income taxÌý


444


894


1,673


2,965














Income tax expenses


79


143


306


475














Net incomeÌý


365


751


1,367


2,490

























Earnings per share:











Basic net income per ordinary share


0.05


0.11


0.20


0.38














Diluted net income per ordinary share


0.05


0.11


0.20


0.38














Weighted average number of ordinary shares used to compute











basic net income per ordinary share (in thousands)


6,715


6,706


6,715


6,541














Weighted average number of ordinary shares used to compute











diluted net income per ordinary share (in thousands)


6,784


6,764


6,785


6,628














Ìý

Eltek Ltd.

Consolidated Balance Sheets

U.S dollars in thousandsÌý

























June 30,


December 31,









2025


2024
















Assets






















Current assets:











Cash and cash equivalents


1,770


7,575







Short-term bank deposits


9,385


9,663







Trade receivables (net of allowance for credit losses)


14,480


11,786







InventoriesÌý


12,874


9,488







Other accounts receivable and prepaid expenses


404


602


















Total current assets


38,913


39,114


















Long term assets:











Severance pay fund


61


56







Deferred tax assets, net


334


496







Operating lease right of use assets


6,409


5,911







Total long term assets


6,804


6,463


















Property and equipment, net


18,703


14,578


















Total Assets


64,420


60,155


















Liabilities and Shareholder's equity






















Current liabilities:











Trade payables


7,197


7,367







Other accounts payable and accrued expenses


5,527


5,136







Short-term operating lease liabilities


1,047


827


















Total current liabilities


13,771


13,330


















Long-term liabilities:











Accrued severance pay


525


443







Long-term operating lease liabilities


5,477


5,190


















Total long-term liabilities


6,002


5,633


















Shareholders' equity:











Ordinary shares of NIS 3.0 par value � Authorized: 10,000,000 shares at June
30, 2025 and December 31, 2024; Issued and outstanding: 6,715,624 shares
at June 30, 2025 and 6,714,040 shares at December 31, 2024


6,012


6,011







Additional paid-in capital


32,634


32,627







Foreign currency translation adjustments


3,750


664







Capital reserve


2,777


2,507







Accumulated deficit


(526)


(617)







Total shareholders' equity


44,647


41,192







Total liabilities and shareholders' equity


64,420


60,155


















Ìý

Eltek Ltd.

Unaudited Non-GAAP EBITDA Reconciliations

U.S dollars in thousandsÌý

























Three months ended


Six months ended




June 30,


June 30,




2025


2024


2025


2024




















GAAP net incomeÌý


365


751


1,367


2,490


Add back items:




















Financial income, netÌý


1,012


(489)


508


(839)


Income tax expensesÌý


79


143


306


475


Depreciation and amortization


500


388


966


753


Non-GAAP EBITDA


1,956


793


3,147


2,879












Ìý

Eltek Ltd.

Consolidated Statement ofÌý Cash flow

U.S dollars in thousandsÌý

























Three months ended


Six months ended





June 30,


June 30,





2025


2024


2025


2024














Cash flows from operating activities:






















Net Income


365


751


1,367


2,490



Adjustments to reconcile net income to net cash flows











provided by operating activities:











Depreciation


500


388


967


753



Unrealized financing expenses (income), net


595


(98)


466


(186)



Share-based compensation


132


154


270


286



Decrease in deferred tax assetsÌý


120


(100)


202


91





1,347


344


1,905


944














Decrease (increase) in operating lease right-of-use assets


(1)


2


-


3



Decrease (increase) in trade receivables


(1,378)


(219)


(1,733)


517



Decrease (increase) in other receivables and prepaid expenses


314


234


247


309



Decrease (increase) in inventories


(2,282)


(169)


(2,612)


(565)



Increase (decrease) in trade payables


(1,138)


955


(2,000)


(536)



Increase (decrease) in other liabilities and accrued expenses


(201)


(48)


(28)


(249)



Increase (decrease)Ìý in employee severance benefits, net


39


(48)


46


(30)





(4,647)


707


(6,080)


(551)














Net cash provided by (used in) operating activities


(2,935)


1,802


(2,808)


2,883

























Cash flows from investing activities:











Purchase of fixed assets


(1,743)


(3,215)


(2,880)


(5,947)



Withdrawal of (investment in) short-term bank deposits, net


-


(132)


534


(6,534)



Net cash used in investing activities


(1,743)


(3,347)


(2,346)


(12,481)

























Cash flows from financing activities:











Exercise of options


8


16


8


261



Dividend distribution


(1,276)


-


(1,276)


-



Issuance of shares, net


-


-


-


9,312



Net cash provided by (used in) financing activities


(1,268)


16


(1,268)


9,573














Effect of translation adjustments


1,250


(204)


617


(376)














Net increase (decrease) in cash and cash equivalents


(4,696)


(1,733)


(5,805)


(401)














Cash and cash equivalents at the beginning of the period


6,466


10,610


7,575


9,278














Cash and cash equivalents at the end of the period


1,770


8,877


1,770


8,877



Logo - https://mma.prnewswire.com/media/881148/5208248/Eltek_Logo.jpg

Cision View original content:

SOURCE Eltek Ltd.

FAQ

What were Eltek's (NASDAQ:ELTK) Q2 2025 earnings results?

Eltek reported Q2 2025 revenues of $12.5 million (up 20% YoY), with operating income of $1.5 million and net income of $0.4 million ($0.05 per share).

How did currency fluctuations affect Eltek's Q2 2025 performance?

The sharp appreciation of the Israeli shekel resulted in a $1.0 million non-cash financial expense, significantly impacting net income. The company has updated its pricing model to better align with NIS-based expenses.

What is the status of Eltek's production capacity expansion plan?

While existing equipment has been successfully installed, the delivery of new 60-meter coating lines has been delayed until late 2025. Construction to accommodate the new lines is progressing on schedule without impacting current operations.

How has Eltek's gross margin improved in Q2 2025?

Eltek's gross margin expanded to 24.1% from 15.6% year-over-year, driven by operational improvements and a favorable product mix.

What drove Eltek's revenue growth in Q2 2025?

Strong momentum across defense and medical segments drove the 20% year-over-year revenue growth, supported by a 10% workforce expansion since January to meet increasing demand.
Eltek Ltd

NASDAQ:ELTK

ELTK Rankings

ELTK Latest News

ELTK Latest SEC Filings

ELTK Stock Data

69.09M
3.17M
52.74%
11.48%
0.26%
Electronic Components
Technology
Israel
Petah Tikva